PPV 03Alternative Names: Anti-IL-23 vaccine - Peptinov; Anti-IL-23p19 vaccine - Peptinov; PPV-03
Latest Information Update: 25 Jul 2016
At a glance
- Originator Peptinov
- Class Immunotherapies; Peptide vaccines
- Mechanism of Action Interleukin-23 subunit p19 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Rheumatoid arthritis
Most Recent Events
- 25 Jul 2016 Preclinical trials in Rheumatoid arthritis in France (Parenteral)